10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lipid nanoparticles (LNPs) have been employed for drug delivery in small molecules, siRNA, mRNA, and pDNA for both therapeutics and vaccines. Characterization of LNPs is challenging because they are heterogeneous mixtures of large complex particles. Many tools for particle size characterization, such as dynamic and static light scattering, have been applied as well as morphology analysis using electron microscopy. CE has been applied for the characterization of many different large particles such as liposomes, polymer, and viruses. However, there have been limited efforts to characterize the surface charge of LNPs and CIEF has not been explored for this type of particle. Typically, LNPs for delivery of oligonucleotides contain at least four different lipids, with at least one being an ionizable cationic lipid. Here, we describe the development of an imaged capillary isoelectric focusing method used to measure the surface charge (i.e., pI) of an LNP‐based mRNA vaccine. This method is capable of distinguishing the pI of LNPs manufactured with one or more different ionizable lipids for the purpose of confirming LNP identity in a manufacturing setting. Additionally, the method is quantitative and stability‐indicating making it suitable for both process and formulation development.

          Related collections

          Most cited references9

          • Record: found
          • Abstract: not found
          • Article: not found

          Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.

            A fully scalable and extrusion-free method was developed to prepare rapidly and reproducibly stabilized plasmid lipid particles (SPLP) for nonviral, systemic gene therapy. Liposomes encapsulating plasmid DNA were formed instantaneously by mixing lipids dissolved in ethanol with an aqueous solution of DNA in a controlled, stepwise manner. Combining DNA-buffer and lipid-ethanol flow streams in a T-shaped mixing chamber resulted in instantaneous dilution of ethanol below the concentration required to support lipid solubility. The resulting DNA-containing liposomes were further stabilized by a second stepwise dilution. Using this method, monodisperse vesicles were prepared with particle sizes less than 200 nm and DNA encapsulation efficiencies greater than 80%. In mice possessing Neuro 2a tumors, SPLP demonstrated a 13 h circulation half-life in vivo, good tumor accumulation and gene expression profiles similar to SPLP previously prepared by detergent dialysis. Cryo transmission electron microscopy analysis showed that SPLP prepared by stepwise ethanol dilution were a mixed population of unilamellar, bilamellar, and oligolamellar vesicles. Vesicles of similar lipid composition, prepared without DNA, were also <200 nm but were predominantly bilamellar with unusual elongated morphologies, suggesting that the plasmid particle affects the morphology of the encapsulating liposome. A similar approach was used to prepare neutral egg phosphatidylcholine:cholesterol (EPC:Chol) liposomes possessing a pH gradient, which was confirmed by the uptake of the lipophilic cation safranin O. This new method will enable the scale-up and manufacture of SPLP required for preclinical and clinical studies. Additionally, this method now allows for the acceleration of SPLP formulation development, enabling the rapid development and evaluation of novel carrier systems.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.

              Lipid nanoparticles (LNPs) represent the most clinically advanced technology for the systemic delivery of therapeutic siRNA in vivo. Toward this end, a novel class of LNPs comprising low molecular weight (MW) ionizable amino lipids having asymmetric architecture was recently reported.1 LNPs of these amino lipids, termed asymmetric LNPs, were shown to be highly efficacious and well tolerated in vivo; advances were enabled by improved endosomal escape, coupled with enhanced amino lipid metabolism and clearance. In this work, we show that, in contrast to their desirable pharmacological performance, asymmetric LNPs present a significant pharmaceutical developability challenge, namely physical instability limiting extended shelf life. Using orthogonal characterization methods, we identify the mechanism of LNP instability as Ostwald ripening and establish it to be driven predominantly by the asymmetric amino lipid component. Through rational optimization of LNP physical and macromolecular properties, we are able to significantly attenuate or entirely eliminate the Ostwald ripening instability. Modulation of LNP size, for example, effectively halts particle growth. Similarly, optimization of LNP macromolecular packing through deliberate selection of structurally matched colipids significantly diminishes the rate of ripening. This later experimental observation is substantiated by molecular dynamics simulations of LNP self-assembly, which establish a quantitative dependence of LNP macromolecular order on colipid structure. In totality, the experimental and molecular dynamics outcomes of this work support the rational design of LNP physical and chemical properties leading to effective Ostwald ripening stabilization and enable the advance of asymmetric LNPs as a clinic-ready platform for siRNA therapeutics.
                Bookmark

                Author and article information

                Contributors
                John_Loughney@merck.com
                Journal
                Electrophoresis
                Electrophoresis
                10.1002/(ISSN)1522-2683
                ELPS
                Electrophoresis
                John Wiley and Sons Inc. (Hoboken )
                0173-0835
                1522-2683
                24 July 2019
                September 2019
                : 40
                : 18-19 , Celebrating Professor Ziad El Rassi's 70 th Birthday and His 25 Years of Dedication to Electrophoresis ( doiID: 10.1002/elps.v40.18-19 )
                : 2602-2609
                Affiliations
                [ 1 ] Vaccine Analytical Research & Development Merck and Co. Inc. West Point PA USA
                Author notes
                [*] [* ] Correspondence: John W. Loughney, 770 Sumneytown Pike, P. O. Box 4, WP42A‐30, West Point, PA 19486, USA

                Email: John_Loughney@ 123456merck.com

                Fax: +1 (215) 993 2244

                Author information
                https://orcid.org/0000-0002-9583-0423
                Article
                ELPS7016
                10.1002/elps.201900063
                6771570
                31218707
                f80b1e4c-e1b4-49b8-80a9-7c5af9c45973
                © 2019 The Authors. Electrophoresis published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 27 January 2019
                : 09 June 2019
                : 10 June 2019
                Page count
                Figures: 5, Tables: 0, Pages: 8, Words: 4494
                Categories
                Research Article
                Part V. Particle and Cell Analysis
                Custom metadata
                2.0
                elps7016
                September 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.9 mode:remove_FC converted:01.10.2019

                Analytical chemistry
                cationic lipid,imaged capillary isoelectric focusing,isoelectric point (pi),lipid nanoparticles,maurice,mrna vaccine

                Comments

                Comment on this article